Could Novo Nordisk's New Weight-Loss Pill Be Just What Its Stock Needs?

Key Takeaways Novo Nordisk shares soared Tuesday after the company said the Food and Drug Administration approved an oral version of its popular Wegovy weight-loss drug.The Danish drugmaker said it hopes to launch the pill in the U.S. in early January. Could a new weight-loss pill be just what Novo Nordisk (NVO) needs to revive its stock? U.S.-listed shares of the Danish drugmaker surged 9% in recent trading after the company said it received Food and Drug Administration approval for an oral version of ...